JP2009539943A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009539943A5 JP2009539943A5 JP2009514811A JP2009514811A JP2009539943A5 JP 2009539943 A5 JP2009539943 A5 JP 2009539943A5 JP 2009514811 A JP2009514811 A JP 2009514811A JP 2009514811 A JP2009514811 A JP 2009514811A JP 2009539943 A5 JP2009539943 A5 JP 2009539943A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- substituted
- unsubstituted
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@](C(CC=C1OC)OC1=O)C=C(C)C=CC=CC(NC(C(C)(C)C)C(NC=CC[C@@](*)CC=CC)=O)=O Chemical compound C[C@](C(CC=C1OC)OC1=O)C=C(C)C=CC=CC(NC(C(C)(C)C)C(NC=CC[C@@](*)CC=CC)=O)=O 0.000 description 2
- YWHOYBGQKJYALK-TWWULKJXSA-N CC(C)C(C(N/C=C\CC(C/C=C(\C)/Cl)OC(N)=O)=O)NC(/C=C\C=C/C(/C)=C/C(C)C(CC=C1OC)OC1=O)=O Chemical compound CC(C)C(C(N/C=C\CC(C/C=C(\C)/Cl)OC(N)=O)=O)NC(/C=C\C=C/C(/C)=C/C(C)C(CC=C1OC)OC1=O)=O YWHOYBGQKJYALK-TWWULKJXSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06380173.2 | 2006-06-16 | ||
| EP06380173 | 2006-06-16 | ||
| PCT/EP2007/055959 WO2007144423A1 (en) | 2006-06-16 | 2007-06-15 | Antitumoral dihydropyran-2-one compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011220925A Division JP2012021023A (ja) | 2006-06-16 | 2011-10-05 | 抗腫瘍ジヒドロピラン−２−オン化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009539943A JP2009539943A (ja) | 2009-11-19 |
| JP2009539943A5 true JP2009539943A5 (enExample) | 2011-11-24 |
| JP5117491B2 JP5117491B2 (ja) | 2013-01-16 |
Family
ID=38508885
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009514811A Expired - Fee Related JP5117491B2 (ja) | 2006-06-16 | 2007-06-15 | 抗腫瘍ジヒドロピラン−２−オン化合物 |
| JP2011220925A Pending JP2012021023A (ja) | 2006-06-16 | 2011-10-05 | 抗腫瘍ジヒドロピラン−２−オン化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011220925A Pending JP2012021023A (ja) | 2006-06-16 | 2011-10-05 | 抗腫瘍ジヒドロピラン−２−オン化合物 |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US8324406B2 (enExample) |
| EP (3) | EP2404913A3 (enExample) |
| JP (2) | JP5117491B2 (enExample) |
| KR (1) | KR101474031B1 (enExample) |
| CN (2) | CN102336730A (enExample) |
| AR (1) | AR061506A1 (enExample) |
| AT (1) | ATE522514T1 (enExample) |
| AU (1) | AU2007259257B8 (enExample) |
| BR (2) | BRPI0713031B8 (enExample) |
| CA (1) | CA2654334C (enExample) |
| CY (1) | CY1112103T1 (enExample) |
| DK (1) | DK2032551T3 (enExample) |
| ES (1) | ES2371942T3 (enExample) |
| HR (1) | HRP20110845T1 (enExample) |
| IL (1) | IL195676A (enExample) |
| MX (1) | MX2008015754A (enExample) |
| MY (1) | MY145788A (enExample) |
| NO (2) | NO341508B1 (enExample) |
| NZ (1) | NZ573706A (enExample) |
| PL (1) | PL2032551T3 (enExample) |
| PT (1) | PT2032551E (enExample) |
| RS (1) | RS52034B (enExample) |
| RU (2) | RU2444519C2 (enExample) |
| SG (1) | SG174830A1 (enExample) |
| SI (1) | SI2032551T1 (enExample) |
| TW (2) | TWI373469B (enExample) |
| UA (1) | UA97369C2 (enExample) |
| WO (1) | WO2007144423A1 (enExample) |
| ZA (1) | ZA200810315B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2597091B1 (en) | 2007-12-20 | 2016-04-20 | Pharma Mar, S.A. | Antitumoral Compounds |
| MX2010008922A (es) | 2008-02-20 | 2010-09-07 | Actelion Pharmaceuticals Ltd | Compuestos antibioticos azatriciclicos. |
| ES2398939T3 (es) | 2008-02-22 | 2013-03-22 | Actelion Pharmaceuticals Ltd. | Derivados de oxazolidinona |
| MY158520A (en) | 2008-10-07 | 2016-10-14 | Actelion Pharmaceuticals Ltd | Tricyclic oxazolidinone antibiotic compounds |
| BRPI0920870A2 (pt) | 2008-10-10 | 2018-06-26 | Actelion Pharmaceuticals Ltd | antibióticos de oxazolidinila. |
| WO2010149688A2 (en) | 2009-06-24 | 2010-12-29 | Pharma Mar, S.A. | Antitumoral compounds |
| GB201309807D0 (en) * | 2013-05-31 | 2013-07-17 | Pharma Mar Sau | Antibody drug conjugates |
| CN108467378A (zh) * | 2017-02-23 | 2018-08-31 | 复旦大学 | 一种二氢吡喃酮类化合物及其制备方法和用途 |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
| CN110790737B (zh) * | 2019-11-07 | 2022-07-22 | 河南中烟工业有限责任公司 | 一种2,3-二氢-3,5-二羟基-6-乙基-4h-吡喃-4-酮的制备方法 |
| TW202330486A (zh) | 2021-10-22 | 2023-08-01 | 西班牙商瑪製藥股份有限公司 | 抗腫瘤化合物 |
| CN117510448A (zh) * | 2023-11-13 | 2024-02-06 | 贵州中医药大学 | 一种二氢吡喃酮衍生物及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| PT1142887E (pt) * | 1993-11-19 | 2004-08-31 | Parke Davis & Co | Derivados de 5,6-di-hidropirona como inibidores de protease e agentes antivirais |
| US7446196B2 (en) * | 2004-06-03 | 2008-11-04 | Kosan Biosciences, Incorporated | Leptomycin compounds |
-
2007
- 2007-06-15 WO PCT/EP2007/055959 patent/WO2007144423A1/en not_active Ceased
- 2007-06-15 RU RU2009101150/04A patent/RU2444519C2/ru active
- 2007-06-15 CN CN2011102036625A patent/CN102336730A/zh active Pending
- 2007-06-15 AU AU2007259257A patent/AU2007259257B8/en not_active Ceased
- 2007-06-15 JP JP2009514811A patent/JP5117491B2/ja not_active Expired - Fee Related
- 2007-06-15 EP EP11177479A patent/EP2404913A3/en not_active Withdrawn
- 2007-06-15 EP EP11177474A patent/EP2404912A3/en not_active Withdrawn
- 2007-06-15 MY MYPI20085040A patent/MY145788A/en unknown
- 2007-06-15 MX MX2008015754A patent/MX2008015754A/es active IP Right Grant
- 2007-06-15 EP EP07765445A patent/EP2032551B9/en active Active
- 2007-06-15 NZ NZ573706A patent/NZ573706A/en not_active IP Right Cessation
- 2007-06-15 SG SG2011067998A patent/SG174830A1/en unknown
- 2007-06-15 AT AT07765445T patent/ATE522514T1/de active
- 2007-06-15 PT PT07765445T patent/PT2032551E/pt unknown
- 2007-06-15 BR BRPI0713031A patent/BRPI0713031B8/pt not_active IP Right Cessation
- 2007-06-15 HR HR20110845T patent/HRP20110845T1/hr unknown
- 2007-06-15 CN CN2007800222645A patent/CN101679340B/zh not_active Expired - Fee Related
- 2007-06-15 ES ES07765445T patent/ES2371942T3/es active Active
- 2007-06-15 DK DK07765445.7T patent/DK2032551T3/da active
- 2007-06-15 KR KR1020097000830A patent/KR101474031B1/ko not_active Expired - Fee Related
- 2007-06-15 SI SI200730781T patent/SI2032551T1/sl unknown
- 2007-06-15 BR BRPI0722429-0A patent/BRPI0722429A2/pt not_active IP Right Cessation
- 2007-06-15 PL PL07765445T patent/PL2032551T3/pl unknown
- 2007-06-15 UA UAA200900292A patent/UA97369C2/ru unknown
- 2007-06-15 RS RS20110495A patent/RS52034B/sr unknown
- 2007-06-15 US US12/304,123 patent/US8324406B2/en not_active Expired - Fee Related
- 2007-06-15 CA CA2654334A patent/CA2654334C/en active Active
- 2007-06-19 AR ARP070102670A patent/AR061506A1/es active IP Right Grant
- 2007-06-20 TW TW096122071A patent/TWI373469B/zh not_active IP Right Cessation
- 2007-06-20 TW TW100146802A patent/TW201213316A/zh unknown
-
2008
- 2008-12-02 IL IL195676A patent/IL195676A/en active IP Right Grant
- 2008-12-04 ZA ZA2008/10315A patent/ZA200810315B/en unknown
-
2009
- 2009-01-06 NO NO20090054A patent/NO341508B1/no unknown
-
2011
- 2011-06-29 US US13/171,567 patent/US8501968B2/en not_active Expired - Fee Related
- 2011-08-05 RU RU2011133128/04A patent/RU2011133128A/ru not_active Application Discontinuation
- 2011-09-14 NO NO20111248A patent/NO20111248L/no not_active Application Discontinuation
- 2011-10-05 JP JP2011220925A patent/JP2012021023A/ja active Pending
- 2011-11-30 CY CY20111101175T patent/CY1112103T1/el unknown